<DOC>
	<DOCNO>NCT01910480</DOCNO>
	<brief_summary>The purpose study : learn safety study drug ( NBI-98854 ) ; learn subject tolerate study drug ; evaluate compare pharmacokinetics ( PK testing , study body absorbs , distributes , break eliminate drug ) investigational study drug take alone ketoconazole . Ketoconazole known affect PK many drug study safely prescribe medication .</brief_summary>
	<brief_title>Study Assess Effect Ketoconazole Pharmacokinetics NBI-98854 Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>Healthy male female volunteer , 18 40 year age . Subjects childbearing potential must agree use hormonal two form nonhormonal birth control study . Female subject must pregnant , give birth within 1 year study start , breastfeeding . Be good general health expect complete clinical study design . Have body mass index ( BMI ) 18 30 kg/m2 ( inclusive ) . Have active clinically significant unstable medical condition within 1 month ( 30 day ) prior screen . Have history substance dependence substance ( drug ) alcohol abuse within 3 month study start . Report two alcoholic beverage daily 14 alcoholic beverage weekly withing 7 day study start . Report use tobacco and/or nicotinecontaining product within 3 month study start . Have know history neuroleptic malignant syndrome . Have significant risk suicidal violent behavior . Have positive human immunodeficiency virus antibody , ( HIVAb ) , hepatitis B surface antigen ( HBsAg ) , hepatitis C virus ( HCV ) antibody result screen history positive result . Have receive investigational drug within 30 day screen plan use investigational drug ( NBI98854 ) study . Have allergy , hypersensitivity , intolerance tetrabenazine . Had blood loss great equal 500 mL donate blood within 56 day study start . Have previous exposure NBI98854 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>